Yann Mazabraud
Corporate Officer/Principal chez RHYTHM PHARMACEUTICALS, INC.
Fortune : 1 M $ au 31/05/2024
Postes actifs de Yann Mazabraud
Sociétés | Poste | Début | Fin |
---|---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/10/2020 | - |
Historique de carrière de Yann Mazabraud
Anciens postes connus de Yann Mazabraud
Sociétés | Poste | Début | Fin |
---|---|---|---|
TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2017 | 03/10/2020 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2016 | 01/10/2017 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Formation de Yann Mazabraud
Groupe de Sup de Co La Rochelle | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
France | 2 |
Royaume-Uni | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TREVI THERAPEUTICS, INC. | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Yann Mazabraud
- Expérience